| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.02T | 1.06T | 1.01T | 1.06T | 918.58B |
| Gross Profit | 261.03B | 253.95B | 222.19B | 215.51B | 269.04B |
| EBITDA | 143.61B | 146.41B | 124.36B | 117.67B | 184.71B |
| Net Income | 41.62B | 58.00B | 57.33B | 50.34B | 107.94B |
Balance Sheet | |||||
| Total Assets | 1.41T | 1.33T | 1.29T | 1.19T | 1.09T |
| Cash, Cash Equivalents and Short-Term Investments | 179.62B | 141.55B | 149.81B | 120.15B | 161.52B |
| Total Debt | 228.91B | 185.46B | 183.13B | 182.96B | 95.22B |
| Total Liabilities | 489.81B | 424.88B | 431.18B | 400.05B | 327.94B |
| Stockholders Equity | 831.79B | 827.11B | 794.56B | 738.89B | 709.10B |
Cash Flow | |||||
| Free Cash Flow | 44.73B | 26.35B | 58.26B | -95.86B | 64.13B |
| Operating Cash Flow | 114.56B | 106.24B | 116.97B | -16.24B | 108.61B |
| Investing Cash Flow | -72.13B | -81.57B | -59.94B | -78.73B | -43.52B |
| Financing Cash Flow | -9.71B | -37.92B | -31.22B | 50.17B | -57.85B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥15.31T | 30.35 | 11.19% | 2.17% | 0.50% | -6.23% | |
66 Neutral | ¥2.43T | 15.26 | 8.29% | 2.89% | 1.22% | 19.36% | |
64 Neutral | ¥875.08B | 20.61 | 4.79% | 4.21% | -4.09% | -27.31% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ¥999.17B | 16.30 | 8.79% | 2.68% | -10.66% | 57.43% | |
56 Neutral | ¥385.81B | 24.59 | -4.00% | 3.71% | -4.00% | ― | |
53 Neutral | ¥1.52T | 133.33 | 1.09% | 3.50% | -15.96% | -74.31% |